# Colossal Biosciences in talks to raise capital at $20B-$30B valuation

Colossal Biosciences, the de-extinction company focused on reviving species like the woolly mammoth, is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion. This would roughly triple its previous valuation, signaling intense investor interest in its gene-editing and conservation technology. The deal highlights growing confidence in the commercial potential of synthetic biology.

**Importance:** 4/5

## Sources

### Technology
- [TechCrunch](https://techcrunch.com/2026/07/20/colossal-biosciences-reportedly-in-talks-to-raise-new-capital-at-20b-30b-valuation/) — Mon, 20 Jul 2026 23:39:35 +0000